Announcement
18 Jun 2026
In June 2026, the Office of the United States Trade Representative announced the initiation of a Section 301 investigation into Germany's pricing policies and practices for innovative pharmaceutical products.
Source
Number of interventions
1
0 certainly harmful
1 likely harmful
0 liberalising
Implementation date
No implementation date
Revocation date:
No revocation date
Recent update from 19 Jun 2026:
On 18 June 2026, the Office of the United States Trade Representative (USTR) announced the initiation of a Section 301 investigation into Germany's acts, policies, and practices related to the pric...
See all
This Thread captures economic policy interventions by the Trump administration aimed at influencing foreign government behaviour since 2025. It includes trade, investment and industrial policy actions where official statements or documentation indicate intent to pressure specific foreign governments to change their policies or practices.
Published: 03 Feb 2025
225
1
This Thread tracks investigation-triggered trade instruments. These policies resemble traditional trade remedies but they operate outside WTO disciplines (i.e. no multilateral framework defines what counts as injury, what evidence is required, or how remedies are calibrated). Examples include US Sections 301 and 232, China's Trade Barriers Investigation regulation, and the EU's Trade Barriers...
Published: 01 May 2026
114
30
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
71357
194